Changwei Lin
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 28
- Circular RNAs in diseases 17
- RNA Research and Splicing 12
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 7
-
- Cancer-related molecular mechanisms research 34
- MicroRNA in disease regulation 21
- Co-authors
- Xiaorong Li (40 shared papers)Yi Zhang (23 shared papers)Gui Hu (23 shared papers)Shaojing Zhao (4 shared papers)Xiuli Zheng (2 shared papers)Ting Xu (2 shared papers)Daojiang Li (13 shared papers)Runliu Wu (10 shared papers)
- Journals
- Oncotarget (8 papers)Oncology Reports (5 papers)Cancers (4 papers)Cell Death and Disease (4 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Changwei Lin
102 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1.3k
- Molecular Biology 1.8k
- Pulmonary and Respiratory Medicine 447
- Biomedical Engineering 462
- Oncology 284
Countries citing papers authored by Changwei Lin
This map shows the geographic impact of Changwei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwei Lin more than expected).
Fields of papers citing papers by Changwei Lin
This network shows the impact of papers produced by Changwei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwei Lin. The network helps show where Changwei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Changwei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances and perspectives in organic sonosensitizers for sonodynamic therapy Hit paper breakdown → | 2021 | 259 |
| 2 | 2019 | 202 | |
| 3 | 2020 | 131 | |
| 4 | 2021 | 127 | |
| 5 | 2021 | 125 | |
| 6 | 2022 | 100 | |
| 7 | 2022 | 99 | |
| 8 | 2021 | 85 | |
| 9 | 2017 | 83 | |
| 10 | 2016 | 69 | |
| 11 | 2015 | 60 | |
| 12 | 2022 | 59 | |
| 13 | 2022 | 54 | |
| 14 | 2018 | 53 | |
| 15 | 2022 | 51 | |
| 16 | 2020 | 50 | |
| 17 | 2012 | 49 | |
| 18 | 2020 | 49 | |
| 19 | 2017 | 47 | |
| 20 | 2000 | 40 |
About Changwei Lin
Changwei Lin is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 105 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (28 papers), MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (17 papers), RNA Research and Splicing (12 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (7 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.8k citations), Pulmonary and Respiratory Medicine (447 citations), Biomedical Engineering (462 citations) and Oncology (284 citations). Changwei Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Xiaorong Li, Yi Zhang, Gui Hu, Shaojing Zhao, Xiuli Zheng, Ting Xu, Daojiang Li, Runliu Wu, Fei Long and Chunxing Yang. Their work appears in journals such as Oncotarget, Oncology Reports, Cancers, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.